A Study to Evaluate the Pharmacokinetics of Adalimumab in Combination With Methotrexate for the Treatment of Patients With Ulcerative Colitis
Latest Information Update: 25 Jun 2021
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 01 Jun 2021 Status changed from active, no longer recruiting to discontinued.
- 25 Oct 2018 Planned End Date changed from 31 Jul 2018 to 31 Jul 2019.
- 25 Oct 2018 Planned primary completion date changed from 31 Jan 2018 to 31 Jul 2019.